Invida Holdings Private Limited, the leading biopharmaceutical commercialization company in Asia-Pacific, is pleased to announce a name change to A. Menarini Asia-Pacific Holdings Pte. Ltd. ("Menarini Asia-Pacific") effective immediately.
Menarini Asia-Pacific's association to its parent company, Menarini Group, allows it unfettered access to a global network of R&D infrastructure. The region also presents vast opportunities for Menarini Group to tap Asia for its R&D ambitions, facilitated by a rapidly expanding patient population, quality data, skilled talents and competitive cost structure.
Building on its reputation of being a fully integrated pharmaceutical company, Menarini Group introduced its research arm – Menarini Ricerche in 1978. This follows the introduction of Italian patent protection regulation, strongly supported by Menarini Group.
Menarini Ricerche covers the full spectrum of research and development, starting with the initial stages of research and the clinical trial phases through to industrial production.
For more information on Menarini Group's research laboratories, please visit: http://www.menarini.com/r_d/R-D-Centers